PRLD Prelude Therapeutics Incorporated

NASDAQ

$3.88

Prelude Therapeutics Incorporated (PRLD) Earnings News

Earnings press releases, previews and reviews for Prelude Therapeutics Incorporated (PRLD), newest first.

Tuesday August 11, 2026 7:00 AM ET

Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Tuesday May 12, 2026 7:01 AM ET

Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update